Compare Acadia Healthcare Company Inc (ACHC) vs JPMorgan Chase & Co (JPM) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Acadia Healthcare Company Inc vs JPMorgan Chase & Co — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while JPMorgan Chase & Co trades at $330.62 (market cap $908.94B). The key difference: JPMorgan Chase & Co is far larger — about 309.2× Acadia Healthcare Company Inc's market cap, and JPMorgan Chase & Co pays a 1.77% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | JPM | |
|---|---|---|
Market Cap | $2.94B | $908.94B |
Sector | Health | Financials |
52-Week High | $31.92 | $339.22 |
52-Week Low | $11.68 | $282.78 |
Enterprise Value | $5.45B | — |
Volume | — | 10,479,943 |
Dividend Yield | — | 1.77% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.
The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.
JPMorgan Chase & Co. (JPM) trades at $330.48, down 2.14% today, amid a bullish technical outlook with moving averages signaling strength. The stock shows solid fundamentals with 2025 revenue of $181.85B and net income of $57.05B, though cash flow trends remain volatile. Recent earnings beat expectations in Q1 2026 with EPS of $5.94, and analyst consensus is a Moderate Buy with a $360.38 price target. CEO Jamie Dimon's shareholder letter highlights economic risks, while institutional activity includes mixed positioning changes.
JPMorgan presents a favorable investment case driven by strong profitability, high ROE of 17.03%, and analyst optimism, but faces headwinds from geopolitical tensions, cybersecurity threats, and fluctuating cash flows. The stock's upside to the consensus target offers potential, yet investors must weigh macroeconomic uncertainties and sector-specific challenges highlighted in recent news.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About JPMorgan Chase & Co
JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.
Read more on JPM →
